- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00347321
Early Percutaneous Tracheostomy for Cardiac Surgery (ETOC) (ETOC)
Evaluation of Early Percutaneous Tracheostomy in Patients Undergoing Cardiovascular Surgery and Requiring Prolonged Mechanical Ventilation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Prolonged mechanical ventilation (MV> 7 days) is required in less than 10% of patients after cardiovascular surgery but it is associated with high morbidity and mortality.
Several studies conducted in critically ill patients suggested that early percutaneous tracheotomy compared with delayed tracheotomy decreases the length of ventilator dependence and improves outcome. To date, no randomized trial has tested these possible benefits in critically ill patients after cardiac surgery.
Study objectives: A randomized trial has been designed to determine whether early tracheostomy (day 4 after cardiac surgery) in patients still on MV would reduce the number of days under MV, measured by the evaluation of ventilator-free days (VFDs). Secondary objectives are the reduction of mortality, reduction of ICU and hospital length of stay. Evaluation of organ failure evolution, infectious complications, sedation needs, patient comfort and outcome at 3 months will be also considered.
Study hypothesis: The trial will be consider positive if early tracheotomy increases the number VFDs of at least 7 days (mean) evaluated on day 60 after randomisation.
Methods :
Trial : randomized, open, controlled, monocentric Inclusion criteria: see columns below Exclusion criteria: see columns below Randomization: will use a computerised system on day 4 after cardiac surgery Procedures: see columns below Recorded data: demographic characteristics, pre, per and postoperative parameters.
From randomization until ICU discharge (or day 60), a daily chart will be completed.
Judgment criteria: see columns below Sample size and statistical analysis: using Wilcoxon bilateral test with an alpha risk of 5% and a power of 80%, we calculated that 108 patients in each arm would be needed.
Statistical analyses will use standard tests to compare population of the two arms.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75013
- Institut de Cardiologie - Chu Pitie Salpetriere Ap-Hp
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Are 18 years of age or older
- Have undergone cardiovascular surgery
- Are still on invasive mechanical ventilation on day 4 after surgery
- Have failed the screening test or the spontaneous breathing trial
- Have signed the informed consent (patient or legal representative)
Exclusion Criteria:
- Age less than18
- Pregnant woman
- Intubation more than 48 hours before cardiovascular surgery
- More than 5 days on mechanical ventilation after cardiac surgery
- Artificial heart implantation
- Concomitant neck surgery (carotid)
- Previously tracheostomized
- Major hemorrhagic risk
- Persistence of platelet count less than 50.000/mm3 after platelet transfusion
- Prothrombin time less than 30% despite coagulation factors administration
- Clinical evidence of ongoing infection at the proposed tracheotomy site
- Anatomical deformity of the neck making risky a tracheostomy
- Probability of dying the day of randomization defined by SAPSII more than 80
- Irreversible neurological lesions
- Decision of care limitation
- Prior inclusion in a trial with morbidity-mortality as main judgement criteria
- Previous enrollment in this trial
- Consent refusal
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Dilatational Percutaneous tracheostomy
|
Dilatational Percutaneous tracheostomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of ventilator-free days defined as the number of days between successful weaning from MV and day 60 after study enrolment.
Time Frame: between successful weaning from MV and day 60 after study enrolment.
|
between successful weaning from MV and day 60 after study enrolment.
|
VFDs = 0 if the patient dies before 60days.
Time Frame: before 60 days
|
before 60 days
|
VFDs= (60- X) : if the patient is successfully weaned from MV within 60 days, where X is the number of days spent receiving MV
Time Frame: during 60 days
|
during 60 days
|
VFDs = 0: if the patient requires MV for 60 days or more
Time Frame: during 60 days and after
|
during 60 days and after
|
The trial will be considered positive if early tracheostomy increases the number VFDs of at least 7 days (mean)
Time Frame: at 7 days
|
at 7 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Other outcomes will be compared between the two arms:
Time Frame: during the trial
|
during the trial
|
Mortality rate (day 60, in-ICU, in-hospital)
Time Frame: during the 60 days
|
during the 60 days
|
ICU length of stay
Time Frame: during the trial
|
during the trial
|
Hospital length of stay
Time Frame: during the trial
|
during the trial
|
Duration of MV in survivors
Time Frame: during the trial
|
during the trial
|
Organ failure evolution
Time Frame: during the trial
|
during the trial
|
Infectious complications
Time Frame: during the trial
|
during the trial
|
Early laryngeal and tracheal complications
Time Frame: during the trial
|
during the trial
|
Sedation needs
Time Frame: during the trial
|
during the trial
|
Patient comfort
Time Frame: during the trial
|
during the trial
|
Outcome on day 90
Time Frame: to 90 days
|
to 90 days
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jean Louis TROUILLET, MD,, Assistance Publique - Hôpitaux de Paris
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P051013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Failure
-
Poitiers University HospitalRecruitingAcute Respiratory Failure | Hypoxemic Respiratory FailureFrance
-
Catholic University of the Sacred HeartFisher and Paykel HealthcareCompletedWeaning Failure | Acute Respiratory FailureFrance, Greece, Italy, Spain
-
Hemovent GmbHMAXIS Medical, LLCActive, not recruitingRespiratory Failure | Cardiac Failure | Cardio-Respiratory FailureGermany
-
Hospital Clinic of BarcelonaCompletedHypercapnic Respiratory Failure | Hypoxemic Respiratory FailureSpain
-
Efficacy Care R&D LtdMemorial Hermann Hospital; CRG Medical, Inc.UnknownShock | Shock, Septic | Respiratory Failure | Respiratory Distress Syndrome | Shock, Cardiogenic | Acute Cardiac Failure | Acute Respiratory Failure | Acute Kidney Failure | Multi Organ Failure | Respiratory Arrest | Acute Respiratory Failure With Hypoxia | Acute Respiratory Failure Requiring Reintubation | Acute... and other conditionsUnited States
-
UPECLIN HC FM Botucatu UnespUnknownExtubation Failure | Acute Respiratory Failure Post ExtubationBrazil
-
Siriraj HospitalRecruitingAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory FailureThailand
-
Fisher and Paykel HealthcareCentre hospitalier de l'Université de Montréal (CHUM); Institut universitaire...Not yet recruitingAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory Failure
-
Hospital Sao JoaoCompletedVentilatory Failure | Post-extubation Failure | Persistent Weaning Failure | Secretion Encumbrance | Weak CoughPortugal
-
Institute of Mountain Emergency MedicineMedical University InnsbruckCompletedHypercapnic Respiratory Failure | Hypoxic Respiratory Failure | Avalanche Burial | Snow Physical PropertiesItaly
Clinical Trials on Dilatational Percutaneous tracheostomy
-
Universitatea de Medicina si Farmacie Iuliu HatieganuRecruitingTracheostomy Complication | Tracheostomy Infection | Tracheostomy HemorrhageRomania
-
Mohamed Sayed Mohamed AbbasCompletedICU Patients Dependant on Mechanical Ventilation : Safest Mode of Performing Percutaneous Tracheostomy Among ICU Ventilated Unweanable Patients
-
University of ChileComisión Nacional de Investigación Científica y TecnológicaUnknown
-
Charles University, Czech RepublicMilitary University Hospital, PragueEnrolling by invitationTracheostomy ComplicationCzechia
-
Melike CengizCompletedTracheostomy ComplicationTurkey
-
Aksaray UniversityNot yet recruitingTracheostomy Complication | Percutaneous Tracheostomy | Airway Trauma | Tracheostomy HemorrhageTurkey
-
Aykut SaritasProf.Dr.A.İlhan Özdemir State HospitalCompletedTracheostomy Complications
-
University of Sao PauloCompletedTracheostomy ComplicationsBrazil
-
Hadassah Medical OrganizationUnknownOther Tracheostomy Complication
-
University of GenovaUnknownHeart Failure | Acute Respiratory Failure | Neurological DiseaseItaly